Free Trial
NASDAQ:TNON

Tenon Medical Q3 2025 Earnings Report

Tenon Medical logo
$1.23 +0.01 (+0.82%)
Closing price 04:00 PM Eastern
Extended Trading
$1.24 +0.01 (+0.81%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tenon Medical EPS Results

Actual EPS
N/A
Consensus EPS
-$0.39
Beat/Miss
N/A
One Year Ago EPS
N/A

Tenon Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.29 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tenon Medical Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Wednesday, November 12, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Tenon Medical Earnings Headlines

How to get compound interest working on your portfolio
I’ve narrowed the entire S&P 500 down to the dividend stocks I’d actually buy myself — including two I’ve already invested $50,000 into — and you can see them all in my free Five Dividend Investing Cheat Sheets.tc pixel
See More Tenon Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tenon Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tenon Medical and other key companies, straight to your email.

About Tenon Medical

Tenon Medical (NASDAQ:TNON) is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue. Lead indications under investigation include soft tissue repair in general and vascular surgery, hernia reinforcement and leak prevention in gastrointestinal procedures. The company advances its candidates through preclinical studies and early-stage clinical evaluations while working with contract manufacturing organizations to scale production in anticipation of regulatory submissions.

Incorporated in 2012, Tenon Medical is led by a management team with backgrounds in medical device innovation, regulatory affairs and commercial development. Headquartered in the United States, the company maintains collaborations with academic institutions and strategic partners to accelerate its development programs. Tenon Medical’s shares trade on the NASDAQ under the ticker symbol TNON.

View Tenon Medical Profile

More Earnings Resources from MarketBeat